CIK 0001217234 · Large accelerated filer
CareDx, Inc.
Sign in to watch- Ticker
- CDNA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943316839
- Phone
- 415-287-2300
- Business address
- 8000 MARINA BLVD, 4TH FLOOR, BRISBANE, CA, 94005
- Former names
- XDx, Inc., EXPRESSION DIAGNOSTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,154,003
- in 2 filings, $5.2M under 10b5-1 plans
Net −$5,154,003. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −997 | $66.23 | $66K | 105,078 |
| 2026-10-01 | Hanna John Walter JR President and CEO | Shares withheld for taxes | −8,511 | $66.23 | $564K | 644,937 |
| 2026-10-01 | Kennedy Keith CFO & COO | Shares withheld for taxes | −3,018 | $66.23 | $200K | 208,686 |
| 2026-09-12 | Meng Jessica Chief Commercial Officer | Shares withheld for taxes | −6,688 | $52.37 | $350K | 161,599 |
| 2026-09-12 | Kennedy Keith CFO & COO | Shares withheld for taxes | −8,220 | $52.37 | $430K | 211,704 |
| 2026-08-05 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −2,188 | $46.15 | $101K | 106,575 |
| 2026-08-05 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 | −500 | $46.75 | $23K | 106,075 |
| 2026-08-05 | Bickerstaff George Director | Sale | −20,000 | $46.29 | $926K | 134,061 |
| 2026-08-04 | Goldberg Michael Director | Sale | −44,700 | $47.06 | $2.1M | 61,738 |
| 2026-08-04 | COURNOYER CHRISTINE Director | Sale 10b5-1 | −16,000 | $46.94 | $751K | 42,943 |
| 2026-08-01 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −2,872 | $47.85 | $137K | 108,763 |
| 2026-07-16 | Valantine Hannah Director | Option exercise 10b5-1 | +7,606 | $20.56 | $156K | 44,292 |
| 2026-07-16 | Valantine Hannah Director | Option exercise 10b5-1 | +16,048 | $14.19 | $228K | 60,340 |
| 2026-07-16 | Valantine Hannah Director | Option exercise 10b5-1 | +5,125 | $7.96 | $41K | 65,465 |
| 2026-07-16 | Valantine Hannah Director | Sale 10b5-1 | −28,679 | $36.14 | $1.0M | 36,786 |
| 2026-07-16 | Valantine Hannah Director | Sale 10b5-1 | −100 | $36.55 | $4K | 36,686 |
| 2026-07-16 | Valantine Hannah Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,606 | 0 | ||
| 2026-07-16 | Valantine Hannah Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,048 | 0 | ||
| 2026-07-16 | Valantine Hannah Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,125 | 24,011 | ||
| 2026-07-16 | Hanna John Walter JR President and CEO | Option exercise 10b5-1 | +118,000 | $8.20 | $968K | 771,448 |
Page 2 of 17 · 324 trades